Chad Rappleye, PhD is an assistant professor in the Department of Microbiology and is jointly appointed in the Center for Micorbial Interface Biology. Dr. Rappleye earned his PhD in Biology from the University of California, San Diego in 2002. He then completed Post-doctoral research at the University of Washington School of Medicine, St. Louis.He joined the faculty in 2006.

Research interests

Dr. Rappleye's laboratory is interested in the molecular mechanisms that underlie the virulence of the respiratory fungal pathogen Histoplasma capsulatum, the causative agent of histoplasmosis.  In particular, they study the interaction between Histoplasma yeasts and their primary host cell, the mammalian macrophage.  Unlike opportunistic pathogens, Histoplasma can cause disease in immunocompetent hosts, implying that Histoplasma has specific mechanisms designed to promote pathogenesis.  One of these mechanisms is the elaboration of a cell wall polysaccharide, alpha-(1,3)-glucan, on the cell surface, which effectively masks the underlying immunostimulatory beta-glucans from detection by the host.  The only other virulence factor identified to date is a secreted molecule of unknown function.  With a genome harboring an estimated 10,000 genes, we have only scratched the surface in defining the genes important for Histoplasma virulence.

Dr. Rappleye's lab is employing genomics-based and molecular genetic approaches to identify additional factors contributing to the pathogenesis of Histoplasma.  The completion of the Histoplasma genome sequence has enabled the construction of microarrays that are used to determine the transcriptional profile of Histoplasma under various conditions, including infection of macrophages.  Once candidate genes have been identified, their importance in virulence is assessed through (i) the creation of loss of function mutants (i.e gene knock-outs) or gene depletion strains (via RNA interference) and (ii) the use of mutant strains in infection studies.  Excellent animal models of disease exist for Histoplasma as well as in vitro culture systems which facilitate more detailed studies to dissect the effect of fungal proteins at the cellular level.

To provide a more complete description of the molecular basis of fungal pathogenesis, his research also investigates the host side of the host-pathogen equation.  Using retroviral and lentiviral RNA interference systems to reduce host gene functions, they can now test the involvement of host molecules in the response to Histoplasma infection.  This ability to perform loss of function experiments in both the host and pathogen combine into a powerful system to define fungal virulence factors and the cognate host pathways targeted. 

Recent publications

Holbrook ED, Rappleye CA. Histoplasma capsulatum pathogenesis: making a lifestyle switch. Curr Opin Microbiol. 2008 Jun 21.

Rappleye CA, Goldman WE. Fungal stealth technology. Trends Immunol. 2008 Jan;29(1):18-24.

Rappleye CA, Eissenberg LG, Goldman WE. Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the beta-glucan receptor.  Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1366-70.

Rappleye CA, Goldman WE.  Defining Virulence Genes in the Dimorphic Fungi.  Annu Rev Microbiol. 2006 Oct;60(1):281-303

Marion CL, Rappleye CA, Engle JT, Goldman WE. An alpha-(1,4)-amylase is essential for alpha-(1,3)-glucan production and virulence in Histoplasma capsulatum. Mol Microbiol. 2006 Nov;62(4):970-83.

Goldman, WE and Rappleye, CA. RNA interference as a tool for studying fungal pathogens.  Nova Acta Leopoldina. 2005 92(344):141-145.

Rappleye CA, Engle JT, Goldman WE.  RNA interference in Histoplasma capsulatum demonstrates a role for alpha-(1,3)-glucan in virulence. Mol Microbiol. 2004 Jul;53(1):153-165.

Contact Info

Ohio State University Department of Microbiology

and the Center for Microbial Interface Biology

540 Biological Sciences Building

484 West 12^th Avenue

Columbus, OH 43210

rappleye.1@osu.edu

office:  614-247-2718

lab:  614-688-4312